Discovery and Validation of Nitroxoline as a Novel STAT3 Inhibitor in Drug-resistant Urothelial Bladder Cancer. | EBSCOhost

Connecting you to content on EBSCOhost

Title: Discovery and Validation of Nitroxoline as a Novel STAT3 Inhibitor in Drug-resistant Urothelial Bladder Cancer.
Authors: Wenfeng Lin; Jingkai Sun; Takuya Sadahira; Naijin Xu; Koichiro Wada; Chunxiao Liu; Motoo Araki; Abai Xu; MasamiWatanabe; Yasutomo Nasu; Peng Huang
Publication: International Journal of Biological Sciences, 2021, Vol 17, Issue 12, p3255
ISSN: 1449-2288
Publication type: Academic Journal
DOI: 10.7150/ijbs.63125